NEW YORK (GenomeWeb News) – MDxHealth today said that it has raised €18 million ($23.6 million) through a private placement of new shares.

The Liege, Belgium-based molecular diagnostics developer said that it issued 8,737,683 shares at a price of €2.06 per share, the average closing price of the firm's shares on the NYSE Euronext market during the 30 preceding calendar days.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Two new Reproducibility Project: Cancer Biology studies have largely reproduced the original findings, ScienceInsider reports.

DNA fingerprinting could catch some sample mix-ups at pathology labs, the New York Times says.

A Maryland police department has turned to DNA phenotyping to develop a suspect sketch, WJLA reports.

In Cell this week: DNA methylation and T cell exhaustion, longevity in C. elegans, and more.